MicroRNA-125a-5p Regulates Cancer Cell Proliferation and Migration Through NAIF1 in Prostate Carcinoma
Overview
Affiliations
Background: We investigated the functional roles of microRNA-125a-5p in regulating human prostate carcinoma.
Methods: Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to evaluate the gene expression levels of miR-125a-5p in eight prostate cancer cell lines and nine biopsy specimens from patients with prostate cancer. miR-125a-5p was genetically knocked down in prostate cancer cell lines, DU145 and VCaP cells by lentiviral transduction. The effects of miR-125a-5p downregulation on prostate cancer cell proliferation and migration were evaluated by MTT assay and transwell assay, respectively. Direct regulation of miR-125a-5p on its downstream targets, NAIF1, and apoptotic gene caspase-3 were evaluated through dual-luciferase reporter assay, qRT-PCR, and Western blot, respectively. NAIF1 was then ectopically overexpressed in DU145 and VCaP cells to modulate prostate cancer cell proliferation and migration. Finally, the effects of miR-125a-5p downregulation or NAIF1 overexpression on the growth of in vivo prostate cancer xenograft were evaluated.
Results: miR-125a-5p was upregulated in prostate cancer cell lines and human prostate carcinomas. Lentivirus induced miR-125a-5p downregulation in DU145 and VCaP cells inhibited prostate cancer cell proliferation or migration. NAIF1 was the direct target of miR-125a-5p, as both gene and protein expression levels of NAIF1, as well as caspase-3 were upregulated by miR-125a-5p. Forced overexpression of NAIF1 had similar antitumor effects as miR-125a-5p downregulation on prostate cancer cell proliferation and migration. In vivo prostate xenograft assay confirmed the tumor-suppressive effect of miR-125a-5p downregulation or NAIF1 overexpression.
Conclusion: miR-125a-5p regulates prostate cancer cell proliferation and migration through NAIF1.
Riddell D, Hildyard J, Harron R, Wells D, Piercy R Wellcome Open Res. 2024; 9:362.
PMID: 39649621 PMC: 11621615. DOI: 10.12688/wellcomeopenres.22481.2.
Etchegaray E, Baas D, Naville M, Haftek-Terreau Z, Volff J Mol Biol Evol. 2022; .
PMID: 35980103 PMC: 9392472. DOI: 10.1093/molbev/msac173.
Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis.
Sheng W, Ding J, Liu L, Wang N, Lu B, You X Evid Based Complement Alternat Med. 2022; 2022:9317402.
PMID: 35942374 PMC: 9356804. DOI: 10.1155/2022/9317402.
Hatmal M, Al-Hatamleh M, Olaimat A, Alshaer W, Hasan H, Albakri K Biomedicines. 2022; 10(6).
PMID: 35740242 PMC: 9219990. DOI: 10.3390/biomedicines10061219.
Li D, Chen L, Zhang X, Wang Y, Huang C, Li J Mol Med Rep. 2021; 24(5).
PMID: 34549308 PMC: 8477177. DOI: 10.3892/mmr.2021.12452.